Xopenex HFA (levalbuterol) is a prescription drug that helps prevent and treat breathing difficulties from sudden airway tightness. The drug comes as an aerosol inhaler. It’s usually used every 4 to 6 ...

COPD - Chronic Obstructive Pulmonary Disease - including chronic bronchitis and emphysema, is characterized by breathing difficulty due to partial blockage of the bronchial tubes. Asthma is a chronic ...

Xopenex HFA (levalbuterol) has potential interactions with other medications and some supplements. These interactions could affect how well the drug works or cause harmful effects. An interaction can ...

DUBLIN--(BUSINESS WIRE)--The "Xopenex - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering. Xopenex Drug Insight, 2019 highlights the drug marketed details and the Global ...

Levalbuterol (as tartrate) (single-isomer albuterol) 45mcg/inh; metered dose inhaler; CFC-free. Do not exceed recommended dose. Monitor for increased need; if inadequate control, reevaluate and ...

Watson Pharmaceuticals has launched an authorized generic version of Xopenex (levalbuterol HCl) Inhalation Solution. This is part of an agreement Watson has with Sunovion Pharmaceuticals, who ...

XOPENEX Inhalation Solution is available for use in a nebulizer at 0.31 mg and 0.63 mg dosage strengths for treatment of children 6 to 11 years old, and in 0.63 mg and 1.25 mg dosage strengths for ...

March 17, 2005 — The U.S. Food and Drug Administration (FDA) has approved a new indication for temozolomide, allowing its use in the first-line treatment of glioblastoma multiforme; orphan drug status ...

Sunovion Pharmaceuticals Inc. to Divest Xopenex® (levalbuterol HCI) Inhalation Solution (IS) to Akorn, Inc. MARLBOROUGH, Mass., Sep 30, 2014 (BUSINESS WIRE) -- Sunovion Pharmaceuticals Inc. (Sunovion) ...

BOSTON (MarketWatch) -- Sepracor Inc. reported lower third-quarter earnings early Tuesday, its bottom-line hurt by decreased sales of its respiratory drug Xopenex due to new Medicare reimbursement ...

Sepracor Inc. had a third-quarter profit of 56 cents a share, exceeding estimates, on higher sales of its Lunesta sleeping pill and Xopenex asthma medication. Net income was $64.4 million, compared ...

Levalbuterol (as tartrate) (single-isomer albuterol) 45mcg/inh; metered dose inhaler; CFC-free. The pharmacological effects of beta 2-adrenoceptor agonist drugs are at least in part attributable to ...